Markers of Hypoxia in Bladder Cancer
Author Information
Author(s): Peter J. Hoskin, A. Sibtain, F. M. Daley, G. D. Wilson
Primary Institution: Mount Vernon Cancer Centre
Hypothesis
Can intrinsic markers of hypoxia predict outcomes in bladder cancer?
Conclusion
Intrinsic markers GLUT1 and CAIX can predict survival in bladder cancer patients.
Supporting Evidence
- GLUT1 and CAIX expression was significantly associated with worse cause-specific and overall survivals.
- Patients with higher levels of GLUT1 had a 5-year overall survival rate of 32% compared to 72% with low levels.
- CAIX expression was predictive of overall survival in bladder cancer patients.
Takeaway
This study looked at how certain markers in bladder cancer can help doctors understand how well a patient might do after treatment.
Methodology
The study involved a prospective cohort of 21 patients and a retrospective review of 64 patients, analyzing tumor samples for markers of hypoxia.
Potential Biases
Potential bias in patient selection and treatment response due to the retrospective nature of part of the study.
Limitations
The study may not generalize to all bladder cancer patients due to the specific cohort and treatment regimens used.
Participant Demographics
Patients included both men and women with muscle-invasive bladder cancer, aged 38 to 88 years.
Statistical Information
P-Value
0.018 for GLUT1 and 0.056 for CAIX in relation to Ki-67.
Confidence Interval
95% CI 1.16–10.22 for CAIX; 95% CI 1.23–10.09 for GLUT1.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website